13
May

The leaders of Pfizer and AstraZeneca are taking turns making their cases to British lawmakers, with the former trying to mollify locals afraid that its planned $106 billion buyout would maim U.K. R&D and the latter working to mount a defense in its home country.

…read more

Source: Pfizer’s quest for AstraZeneca becomes political theater as MPs probe $106B offer

    

0 No comments